However, a larger cohort with multiple subtypes (IDH1 mutation, MGMT methylation etc.)and the data from diverse classified GBM cell lines (classical, proneural, and mesenchymal) will be required to determine this. The gene discussed is MGMT; the disease is glioblastoma.